0.6664
Finanzdaten der Mira Pharmaceuticals Inc-Aktie (MIRA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
4.77%
1.1561
|
1.1035 | 5.8248 | 1.317 | 1.5461 |
| Net Interest Income/Expense |
21.78%
0.0351
|
0.0449 | 0.0532 | 0.0157 | - |
| Nonoperating Income/Loss |
12.30%
-0.0524
|
-0.0467 | -0.1585 | 0.1793 | - |
| Net Income/Loss |
5.08%
-1.2085
|
-1.1502 | -5.9833 | -1.1377 | -1.5377 |
| Basic Average Shares |
0.19%
42.02
|
41.94 | - | 19.27 | 16.99 |
| Basic Earnings Per Share |
0.00%
-0.03
|
-0.03 | - | -1.18 | -0.09 |
| Diluted Earnings Per Share |
0.00%
-0.03
|
-0.03 | - | -1.18 | -0.09 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):